These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 28667482)

  • 21. Rapid myelin water imaging for the assessment of cervical spinal cord myelin damage.
    Dvorak AV; Ljungberg E; Vavasour IM; Liu H; Johnson P; Rauscher A; Kramer JLK; Tam R; Li DKB; Laule C; Barlow L; Briemberg H; MacKay AL; Traboulsee A; Kozlowski P; Cashman N; Kolind SH
    Neuroimage Clin; 2019; 23():101896. PubMed ID: 31276928
    [TBL] [Abstract][Full Text] [Related]  

  • 22. White matter atrophy in brain of neuromyelitis optica: a voxel-based morphometry study.
    Duan Y; Liu Y; Liang P; Jia X; Ye J; Dong H; Li K
    Acta Radiol; 2014 Jun; 55(5):589-93. PubMed ID: 23966367
    [TBL] [Abstract][Full Text] [Related]  

  • 23. "Bright spotty lesions" on spinal magnetic resonance imaging differentiate neuromyelitis optica from multiple sclerosis.
    Yonezu T; Ito S; Mori M; Ogawa Y; Makino T; Uzawa A; Kuwabara S
    Mult Scler; 2014 Mar; 20(3):331-7. PubMed ID: 23828869
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative spinal cord MRI in MOG-antibody disease, neuromyelitis optica and multiple sclerosis.
    Mariano R; Messina S; Roca-Fernandez A; Leite MI; Kong Y; Palace JA
    Brain; 2021 Feb; 144(1):198-212. PubMed ID: 33206944
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative brain stem lesions on MRI of acute disseminated encephalomyelitis, neuromyelitis optica, and multiple sclerosis.
    Lu Z; Zhang B; Qiu W; Kang Z; Shen L; Long Y; Huang J; Hu X
    PLoS One; 2011; 6(8):e22766. PubMed ID: 21853047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased radial diffusivity in spinal cord lesions in neuromyelitis optica compared with multiple sclerosis.
    Klawiter EC; Xu J; Naismith RT; Benzinger TL; Shimony JS; Lancia S; Snyder AZ; Trinkaus K; Song SK; Cross AH
    Mult Scler; 2012 Sep; 18(9):1259-68. PubMed ID: 22354742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spinal cord atrophy in anterior-posterior direction reflects impairment in multiple sclerosis.
    Lundell H; Svolgaard O; Dogonowski AM; Romme Christensen J; Selleberg F; Soelberg Sørensen P; Blinkenberg M; Siebner HR; Garde E
    Acta Neurol Scand; 2017 Oct; 136(4):330-337. PubMed ID: 28070886
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Brain and spinal cord lesion criteria distinguishes AQP4-positive neuromyelitis optica and MOG-positive disease from multiple sclerosis.
    Bensi C; Marrodan M; González A; Chertcoff A; Osa Sanz E; Chaves H; Schteinschnaider A; Correale J; Farez MF
    Mult Scler Relat Disord; 2018 Oct; 25():246-250. PubMed ID: 30144694
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relaxometry and brain myelin quantification with synthetic MRI in MS subtypes and their associations with spinal cord atrophy.
    Ladopoulos T; Matusche B; Bellenberg B; Heuser F; Gold R; Lukas C; Schneider R
    Neuroimage Clin; 2022; 36():103166. PubMed ID: 36081258
    [TBL] [Abstract][Full Text] [Related]  

  • 30. White matter volume is decreased in the brain of patients with neuromyelitis optica.
    Chanson JB; Lamy J; Rousseau F; Blanc F; Collongues N; Fleury M; Armspach JP; Kremer S; de Seze J
    Eur J Neurol; 2013 Feb; 20(2):361-7. PubMed ID: 22978568
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of asymptomatic spinal cord lesions and atrophy with disability 5 years after a clinically isolated syndrome.
    Brownlee WJ; Altmann DR; Alves Da Mota P; Swanton JK; Miszkiel KA; Wheeler-Kingshott CG; Ciccarelli O; Miller DH
    Mult Scler; 2017 Apr; 23(5):665-674. PubMed ID: 27481210
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinically relevant cranio-caudal patterns of cervical cord atrophy evolution in MS.
    Rocca MA; Valsasina P; Meani A; Gobbi C; Zecca C; Rovira À; Montalban X; Kearney H; Ciccarelli O; Matthews L; Palace J; Gallo A; Bisecco A; Gass A; Eisele P; Lukas C; Bellenberg B; Barkhof F; Vrenken H; Preziosa P; Comi G; Filippi M;
    Neurology; 2019 Nov; 93(20):e1852-e1866. PubMed ID: 31611336
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The relationships among MRI-defined spinal cord involvement, brain involvement, and disability in multiple sclerosis.
    Cohen AB; Neema M; Arora A; Dell'oglio E; Benedict RH; Tauhid S; Goldberg-Zimring D; Chavarro-Nieto C; Ceccarelli A; Klein JP; Stankiewicz JM; Houtchens MK; Buckle GJ; Alsop DC; Guttmann CR; Bakshi R
    J Neuroimaging; 2012 Apr; 22(2):122-8. PubMed ID: 21447024
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Poor responses to interferon-beta treatment in patients with neuromyelitis optica and multiple sclerosis with long spinal cord lesions.
    Wang KC; Lin KH; Lee TC; Lee CL; Chen SY; Chen SJ; Chin LT; Tsai CP
    PLoS One; 2014; 9(6):e98192. PubMed ID: 24887452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of grey matter atrophy between patients with neuromyelitis optica and multiple sclerosis: a voxel-based morphometry study.
    Duan Y; Liu Y; Liang P; Jia X; Yu C; Qin W; Sun H; Liao Z; Ye J; Li K
    Eur J Radiol; 2012 Feb; 81(2):e110-4. PubMed ID: 21316170
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cervical and thoracic cord atrophy in multiple sclerosis phenotypes: Quantification and correlation with clinical disability.
    Mina Y; Azodi S; Dubuche T; Andrada F; Osuorah I; Ohayon J; Cortese I; Wu T; Johnson KR; Reich DS; Nair G; Jacobson S
    Neuroimage Clin; 2021; 30():102680. PubMed ID: 34215150
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Brain and cord myelin water imaging: a progressive multiple sclerosis biomarker.
    Kolind S; Seddigh A; Combes A; Russell-Schulz B; Tam R; Yogendrakumar V; Deoni S; Sibtain NA; Traboulsee A; Williams SC; Barker GJ; Brex PA
    Neuroimage Clin; 2015; 9():574-80. PubMed ID: 26594633
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predicting short-term disability progression in early multiple sclerosis: added value of MRI parameters.
    Minneboo A; Jasperse B; Barkhof F; Uitdehaag BM; Knol DL; de Groot V; Polman CH; Castelijns JA
    J Neurol Neurosurg Psychiatry; 2008 Aug; 79(8):917-23. PubMed ID: 18077480
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ongoing microstructural changes in the cervical cord underpin disability progression in early primary progressive multiple sclerosis.
    Cortese R; Tur C; Prados F; Schneider T; Kanber B; Moccia M; Wheeler-Kingshott CAG; Thompson AJ; Barkhof F; Ciccarelli O
    Mult Scler; 2021 Jan; 27(1):28-38. PubMed ID: 31961242
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spinal cord lesions and brain grey matter atrophy independently predict clinical worsening in definite multiple sclerosis: a 5-year, multicentre study.
    Rocca MA; Valsasina P; Meani A; Gobbi C; Zecca C; Barkhof F; Schoonheim MM; Strijbis EM; Vrenken H; Gallo A; Bisecco A; Ciccarelli O; Yiannakas M; Rovira A; Sastre-Garriga J; Palace J; Matthews L; Gass A; Eisele P; Lukas C; Bellenberg B; Margoni M; Preziosa P; Filippi M;
    J Neurol Neurosurg Psychiatry; 2023 Jan; 94(1):10-18. PubMed ID: 36171105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.